Various embodiments disclosed relate to drug-coated balloon catheters for treating, preventing, or reducing the recurrence of a stricture and/or cancer, or for treating benign prostatic hyperplasia (BPH), in a non-vascular body lumen and methods of using the same. A drug-coated balloon catheter for delivering a therapeutic agent to a target site of a body lumen stricture includes an elongated balloon having a main diameter. The balloon catheter includes a coating layer overlying an exterior surface of the balloon. The coating layer includes one or more water-soluble additives and an initial drug load of a therapeutic agent. In some embodiments, the balloon catheter includes a length-control mechanism which stretches and elongates the balloon when it is in a deflated state, giving the balloon a smaller cross-sectional deflated profile for tracking through the body lumen and for removal after treatment.

A catheter comprising: a shaft (1) having a proximal end (2) and a distal end (3), the distal end terminating in a tip (4); a drainage opening (7) located at the distal end of the shaft, the drainage opening communicating with a drainage lumen (8) of the shaft; a balloon located at the distal end of the shaft, the balloon comprising a first region secured to the shaft, a second region secured to the shaft and an elastic-walled conduit extending between the first region and the second region, the elastic conduit extending over the tip.

A catheter device and manufacturing process for manufacturing the catheter device, wherein the catheter device has a halo-shaped coiled portion extending away from a perpendicular stem portion through a swan neck portion. Eyelets on the halo coil portion and swan neck portion facilitate flow out of the bladder through the catheter device vertical to the catheter, rather than perpendicularly as is the case with existing catheters. The catheter device is formed by using a straight catheter tube, heating and cooling it within a formed mold to have the halo coil and swan neck, such that it can be straightened using a pusher and stylet, inserted into the body while straightened, and thereafter return to its coiled shape when the stylet is removed.

An adapter suitable for direct introduction of an active agent, or a contrast agent, into the bladder of a male or female patient without the use of a catheter has an elongated body that defines an internal through passageway and a toroidal sealing collar that surrounds the elongated body at a distal end portion of the elongated body. The distal end portion terminates in a rounded off tip-part sized for insertion into the urethra of the patient. The proximal end portion of the elongated body is adapted for connection to a dosing device.

An intermittent-catheter assembly (100) includes an intermittent catheter and a catheter housing (102). The intermittent catheter includes a funnel and a catheter tube fluidly coupled to the funnel. The catheter housing (102) includes the intermittent catheter disposed in the catheter housing while in a packaged state of the intermittent-catheter assembly. The catheter housing includes an inner sleeve (104) and an outer sleeve (102). The inner sleeve (104) includes a longitudinal cavity containing a majority of the intermittent catheter in the packaged state of the intermittent-catheter assembly. The outer sleeve (106) is slidably disposed over the inner sleeve (104). The catheter housing (102) is configured to expose the intermittent catheter for removal from the catheter housing (102) when the outer sleeve (106) is grasped and slid toward an exposed end of the inner sleeve (104) in opposition to a force applied to the exposed end of the inner sleeve (104).

A ureteral catheter is provided, including a drainage lumen including a proximal portion and a distal portion configured to be positioned in a patient's kidney, renal pelvis, and/or in the ureter adjacent to the renal pelvis, the distal portion including a retention portion for maintaining positioning of the distal portion of the drainage lumen, the retention portion including at least two openings on a sidewall of the retention portion for permitting fluid flow into the drainage lumen wherein a total area of a proximal most opening of the at least two openings is less than a total area of more distal opening(s) nearer to the distal end of the drainage lumen, and wherein when negative pressure is applied through the ureteral catheter, fluid is drawn into the ureteral catheter through the at least two openings.

The disclosure provides a device and method for managing urinary incontinence. The device includes a platform, a balloon, and a valve. The platform and balloon can include a silicone material, a thermoplastic material, and an adhesive and/or a cement for sealing the urethra. The thermoplastic and silicone materials can soften at the body temperature so that their shape can be adapted to fit the three-dimensional contour of surfaces of the urethra. The balloon seals the internal orifice of the urethra, and the platform can block the leakage associated with the balloon. The valve permits selective urine voiding. The method includes inserting the device into the urethra and the bladder. The method can also include inflating the balloon. The method can further include pulling the balloon so that the balloon is in sealing contact with the neck of the bladder and moving the platform to a suitable position for sealing the urethra.

In some aspects, provided herein are antimicrobial compositions comprising partially esterified polygalacturonic acid and certain fatty acids (e.g., caprylic acid). In some embodiments, the antimicrobial composition may be administered (e.g., topically or orally) to a subject, such as a human patient to treat an infection (e.g., an infection comprising a biofilm). In some aspects, improved catheters are provided.

Ureteral bypass devices and procedures for performing internalized urinary diversions within patients. Such a procedure includes implanting a first catheter and securing a distal end of the first catheter within the renal pelvis or ureter of a patient, implanting a cystostomy catheter through and securing a distal end of the cystostomy catheter within the urinary bladder of the patient, fluidically connecting proximal ends of the first and cystostomy catheters to an adapter, and then subcutaneously implanting a sampling/flushing port and fluidically connecting a proximal end of the sampling/flushing port to the adapter via a third catheter to yield an artificial ureteral bypass device, in which the first and cystostomy catheters are fluidically connected together and fluidically connected to the subcutaneously-placed sampling/flushing port.

Disclosed herein are systems, devices, and methods for the removal of objects from the body. The device may be a urethral catheter configured to aspirate kidney stones from the urinary tract through one or more aspiration ports at the distal face or along a lateral side of the catheter. The catheter may include one or more irrigation ports at the distal face or along the lateral side of the catheter for dislodging kidney stones. The device may be steerable. The spatial arrangement of the one or more irrigation ports with respect to the one or more aspiration ports may vary. The device may include an irrigation tube and/or a shield member configured to spatially confine the kidney stones adjacent the catheter. Various temporal patterns of aspiration and irrigation are disclosed for optimizing removal of kidney stones.